mRNA |
crizotinib:PLX-4032 (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
apicidin |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.026 |
0.6 |
mRNA |
phloretin |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
BRD6340 |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.016 |
0.6 |
mRNA |
BRD-K27188169:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.027 |
0.6 |
mRNA |
JQ-1:vorinostat (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Docetaxel |
GDSC1000 |
pan-cancer |
AAC |
0.016 |
0.6 |